deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT05777148

Comparison of Efficacy in Removal of Advanced Glycation End Products (AGEs) Between Super High-flux Hemodialysis and Postdilution Online Hemodiafiltration: A Single-center, Prospective, Open-label, Crossover Randomized Controlled Trial

Sponsor: Mahidol University

Conditions End Stage Renal Disease
Interventions postdilution online hemodiafiltration super high-flux hemodialysis
Updated 4 times since 2023 Last updated: Mar 8, 2023 Started: Apr 4, 2022 Primary completion: Jun 30, 2023 Completion: Jun 30, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates End Stage Renal Disease and is currently ongoing. Mahidol University leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotActive Not Recruiting~Apr 2025 – present · 15 months · monthly snapshotUnknown

Change History

4 versions recorded

  1. Apr 2025 — Present [monthly]

    Unknown NA

    Status: Active Not Recruiting → Unknown

  2. Sep 2024 — Apr 2025 [monthly]

    Active Not Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  4. Apr 2023 — Jul 2024 [monthly]

    Active Not Recruiting NA

    First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mahidol University
Data source: Mahidol University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations